Redan Pharmaceuticals Private Limited
About Redan Pharmaceuticals Private Limited
Data last updated:
Redan Pharmaceuticals Private Limited was a private limited company based in Chandigarh, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 15 July 2008.
The company was registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24119CH2008PTC031305. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It was led by directors Arunaksh Bhardwaj and Rajesh Bhardwaj.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at Plot No. 73 Ground Floor Industrial Area Phase – 2, Chandigarh, India – 160002.
As per the financials filed for FY 2018, the company reported a revenue of ₹6.68 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net loss of ₹16,028 (net margin -2.4%) and EBITDA of -₹11,292 (EBITDA margin -1.7%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
Company details
Contact details
Redan Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No. 73 Ground Floor Industrial Area Phase – 2, Chandigarh, India – 160002
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Redan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Redan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Redan Pharmaceuticals Private Limited, buy the company report.
Financials of Redan Pharmaceuticals Private Limited
FY 2018 filings availableRedan Pharmaceuticals Private Limited reported revenue of ₹6.68 Lakh (down 12% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 12% fall in the latest year. EBITDA rose 91% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹11,292 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹16,028 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.7% | |||
| Net Profit Margin | -2.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Redan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Redan Pharmaceuticals Private Limited
Redan Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arunaksh Bhardwaj | Director | 15 Jul 2008 | 18 Years 3 Months | As last reported |
| Rajesh Bhardwaj | Director | 15 Jul 2008 | 18 Years 3 Months | As last reported |
Peer comparison
Redan Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pametan Pharmaceuticals Private Limited | ₹6.75 Lakh (FY 2018) | Hyderabad, Telangana, India | ||||
| Austus Pharmaceuticals Private Limited | ₹6.73 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Stokem Pharmaceuticals Private Limited | ₹6.7 Lakh (FY 2025) | 2.0% | Purnia, Bihar, India | |||
| Aqutrus Pharmaceuticals Private Limited | ₹6.7 Lakh (FY 2021) | Ahmedabad, Gujarat, India | ||||
| Redan Pharmaceuticals Private Limitedthis company | ₹6.68 Lakh (FY 2018) | -₹16,028 | -2.4% | -12.0% | Chandigarh, India | |
| Sabiscon Pharmaceuticals Private Limited | ₹6.66 Lakh (FY 2025) | 2.0% | Surat, Gujarat, India | |||
| Tacaso Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2025) | 202.0% | Salem, Tamil Nadu, India | |||
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | -78.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Redan Pharmaceuticals Private Limited, buy the company report.
Auditor
Redan Pharmaceuticals Private Limited is audited by R. Raman Gupta & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R. Raman Gupta & Co. | FY 2017 | 010888C |
Shareholding
The shareholding of Redan Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Redan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Redan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Redan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Redan Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Redan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Redan Pharmaceuticals Private Limited has 3 board changes on record since 2008: 2 appointments and 1 cessation. The latest: Manjit Singh Anand ceased to be Director on 16 Oct 2019.
Frequently asked questions
Redan Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Redan Pharmaceuticals was a private limited company based in Chandigarh, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 15 July 2008 and is registered under CIN U24119CH2008PTC031305. The company has been struck off by the Registrar of Companies and is no longer operational.
Redan Pharmaceuticals had 2 directors:
- Arunaksh Bhardwaj - Director
- Rajesh Bhardwaj - Director
The CIN (Corporate Identification Number) of Redan Pharmaceuticals is U24119CH2008PTC031305. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Redan Pharmaceuticals is at Plot No. 73 Ground Floor Industrial Area Phase – 2, Chandigarh, India – 160002.
Redan Pharmaceuticals was incorporated on 15 July 2008. It is registered with the Registrar of Companies, Chandigarh.
The latest financial statements of Redan Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
No. Redan Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
Redan Pharmaceuticals operated in the chemicals industry, in the medicinal chemical and botanical products segment. It worked in this industry before it was struck off.
The peers of Redan Pharmaceuticals by revenue are Pametan Pharmaceuticals Private Limited, Austus Pharmaceuticals Private Limited, Stokem Pharmaceuticals Private Limited, Aqutrus Pharmaceuticals Private Limited, Sabiscon Pharmaceuticals Private Limited and 2 more, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Manjit Singh Anand ceased to be Director on 16 Oct 2019. Arunaksh Bhardwaj was appointed as Director on 15 Jul 2008. Rajesh Bhardwaj was appointed as Director on 15 Jul 2008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
